The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Advocacy: Past Wins, Future Outlook

ACR Advocacy: Past Wins, Future Outlook

January 18, 2018 • By Angus Worthing, MD, FACP, FACR

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CMS Nominee
Alex Azar, the president’s nominee to lead the CMS, testified a second time in front of Congress last week. The good news: He appears to agree with our view that intermediaries, such as PBMs, incentivize higher prices, and he supports government working to reduce drug prices. The bad news: He expressed interest in allowing PBMs to work in the Part B drug space, which could increase rheumatologists’ administrative burden and potentially decrease patient access to treatment. Additionally, he stated support for Medicare demonstrations to be mandatory if needed—a significant departure from when Tom Price, MD, headed the CMS and supported doctors’ ability to opt out of demonstration projects. The Senate will likely vote on Azar’s candidacy soon, and the ACR stands ready to work with him and his team to make sure our profession and our patients are represented at the CMS.

You Might Also Like
  • ACR’s 2017 Advocacy Successes
  • ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins
  • The ACR Announces Advocacy Priorities for 2016
Also By This Author
  • Keeping the Pressure on Congress: ACR Opposes Medicare Payment Adjustment Plan, Executive Order

A Final Note
As we all work on our New Year’s resolutions, remember to go out and exercise your First Amendment right to petition your government! (See what I did there?)

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Angus Worthing, MD, FACP, FACR, chair, Government Affairs Committee, is a practicing rheumatologist in the Washington, D.C., metro area and clinical assistant professor of medicine at Georgetown University.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy, Practice Management, Professional Topics Tagged With: 2017 year in review, 2018 challenges, Angus Worthing, drug costs, Washington D.C. update

You Might Also Like:
  • ACR’s 2017 Advocacy Successes
  • ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins
  • The ACR Announces Advocacy Priorities for 2016
  • The Past & Future of Rheumatology Professionals: ACR/ARHP works to address the challenges we face

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)